Human observational studies have reported increased cancer mortality in those with obesity and type 2 diabetes, which may be attributable to hyperinsulinemia, elevated IGF-1, or potentially both factors. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.